Embody vs MEDVi: Which GLP-1 Provider Is Better?
A side-by-side comparison of Embody and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#21 of 317.8/10
Compounded GLP-1 provider with 24/7 specialist support and competitive pricing for budget-conscious users.
Visit EmbodyHigher Rated
MEDVi
#9 of 318.3/10
Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Embody | MEDVi |
|---|---|---|
| Our Score | 7.8/10 | 8.3/10 |
| Starting Price | $149/mo | $179/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users looking for the lowest entry price with round-the-clock specialist support | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #21 | #9 |
Pros & Cons Compared
Embody
Pros
- +24/7 specialist support
- +Competitive pricing
- +Good for beginners
- +Responsive team
Cons
- −Compounded only
- −No insurance
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Embody with a score of 8.3/10 vs 7.8/10. If budget is your priority, Embody starts at $149/mo compared to MEDVi's $179/mo. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.